Vermillion Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Vermillion Wealth Management's ABBV Position: Q2 2026 in Review
Vermillion Wealth Management reduced its AbbVie (ABBV) stake by 15% in Q2 2026, selling an estimated $26.7K and leaving 692 shares worth $174K. The position accounts for 0.04% of the portfolio, ranked #269.
Vermillion Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $177K in Q1 2026. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Vermillion Wealth Management held 692 shares of AbbVie worth $174K as of Q2 2026.
- Vermillion Wealth Management sold 124 AbbVie shares in Q2 2026, an estimated $26.7K.
- AbbVie made up 0.04% of Vermillion Wealth Management's portfolio in Q2 2026, its #269 holding.
- Vermillion Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
- Vermillion Wealth Management's AbbVie position peaked at $177K in Q1 2026.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.